BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22178776)

  • 1. Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study.
    Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Kang HJ; Song MK; Kim HJ; Kwon JH; Kwak JY; Park BB; Do YR; Jeong SH; Suh C
    Acta Haematol; 2012; 127(2):100-4. PubMed ID: 22178776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study.
    Oh SY; Kim WS; Kim JS; Kim SJ; Kwon HC; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Lee GW; Choi CW; Park J; Suh C; Kim HJ
    Ann Hematol; 2010 Jun; 89(6):563-8. PubMed ID: 20024551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study.
    Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Kang HJ; Choi CW; Park J; Kim HJ; Kwon JH; Lee HS; Lee GW; Eom HS; Kwak JY; Suh C; Kim HJ
    Cancer Sci; 2010 Nov; 101(11):2443-7. PubMed ID: 20831770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal marginal zone B-cell lymphoma of MALT type: clinical manifestation and outcome of a rare disease.
    Oh SY; Kwon HC; Kim WS; Hwang IG; Park YH; Kim K; Ko YH; Ryoo BY; Kang HJ; Nam E; Lee JH; Kim JH; Kim HJ
    Eur J Haematol; 2007 Oct; 79(4):287-91. PubMed ID: 17692101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapsed or refractory nongastric marginal zone B-cell lymphoma: multicenter retrospective analysis of 92 cases.
    Oh SY; Kim WS; Kim SJ; Kim JS; Kim SH; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Kim JG; Yang DH; Kang HJ; Choi CW; Park J; Choi YJ; Kim HJ; Kwon JH; Suh C; Kim HJ
    Am J Hematol; 2009 Dec; 84(12):826-9. PubMed ID: 19890833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma.
    Oh SY; Ryoo BY; Kim WS; Kim K; Lee J; Kim HJ; Kwon JM; Lee HR; Ko YH; Oh SJ; Park KW; Kim HJ; Kwon HC; Nam E; Kim JH; Park YH; Lee SS; Kim HY; Park K
    Ann Hematol; 2006 Nov; 85(11):781-6. PubMed ID: 16847665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nongastric marginal zone B-cell lymphoma: analysis of 247 cases.
    Oh SY; Ryoo BY; Kim WS; Park YH; Kim K; Kim HJ; Kwon JM; Lee J; Ko YH; Ahn YC; Oh SJ; Lee SI; Kim HJ; Kwon HC; Bang SM; Kim JH; Park J; Lee SS; Kim HY; Park K
    Am J Hematol; 2007 Jun; 82(6):446-52. PubMed ID: 17266060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy.
    Wenzel C; Fiebiger W; Dieckmann K; Formanek M; Chott A; Raderer M
    Cancer; 2003 May; 97(9):2236-41. PubMed ID: 12712477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-2-microglobulin levels in patients with extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type: a retrospective analysis.
    Penz MZ; Fiebiger WC; Valencak JB; Osterreicher C; Ba-Ssalamah A; Formanek M; Brodowic T; Chott A; Raderer M
    Anticancer Res; 2001; 21(4B):3049-52. PubMed ID: 11712809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa.
    Lee JL; Kim MK; Lee KH; Hyun MS; Chung HS; Kim DS; Shin SO; Cho HS; Bae SH; Ryoo HM
    Ann Hematol; 2005 Jan; 84(1):13-8. PubMed ID: 15309523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
    Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
    Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacrimal gland extranodal marginal zone B-cell lymphoma of MALT-type.
    Kao SC; Kau HC; Tsai CC; Tsay SH; Yang CF; Wu JS; Hsu WM
    Am J Ophthalmol; 2007 Feb; 143(2):311-316. PubMed ID: 17184716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24553 patients with Hashimoto's disease.
    Watanabe N; Noh JY; Narimatsu H; Takeuchi K; Yamaguchi T; Kameyama K; Kobayashi K; Kami M; Kubo A; Kunii Y; Shimizu T; Mukasa K; Otsuka F; Miyara A; Minagawa A; Ito K; Ito K
    Br J Haematol; 2011 Apr; 153(2):236-43. PubMed ID: 21371004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathologic features of primary thyroid lymphoma].
    Zhou SY; Huang DZ; Shi YK; He XH; Wu YH; Li YX
    Ai Zheng; 2005 Jan; 24(1):95-8. PubMed ID: 15642210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nongastric marginal zone B-cell lymphoma: a prognostic model from a retrospective multicenter study.
    Oh SY; Kwon HC; Kim WS; Park YH; Kim K; Kim HJ; Kwon JM; Lee J; Ko YH; Ahn YC; Oh SJ; Lee SI; Bang SM; Kim JH; Park J; Ryoo BY; Lee SS; Kim HY; Park K; Kim HJ
    Cancer Lett; 2007 Dec; 258(1):90-7. PubMed ID: 17936499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.
    Tsang RW; Gospodarowicz MK; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Patterson BJ
    J Clin Oncol; 2003 Nov; 21(22):4157-64. PubMed ID: 14615444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment of localized gastric marginal zone B-cell mucosa associated lymphoid tissue lymphoma including incidence of metachronous gastric cancer.
    Ono S; Kato M; Takagi K; Kodaira J; Kubota K; Matsuno Y; Komatsu Y; Asaka M
    J Gastroenterol Hepatol; 2010 Apr; 25(4):804-9. PubMed ID: 20492338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: a multicenter Rare Cancer Network study.
    Anacak Y; Miller RC; Constantinou N; Mamusa AM; Epelbaum R; Li Y; Calduch AL; Kowalczyk A; Weber DC; Kadish SP; Bese N; Poortmans P; Kamer S; Ozsahin M
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):315-20. PubMed ID: 21075560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study.
    Pollard RP; Pijpe J; Bootsma H; Spijkervet FK; Kluin PM; Roodenburg JL; Kallenberg CG; Vissink A; van Imhoff GW
    J Rheumatol; 2011 Oct; 38(10):2198-208. PubMed ID: 21844152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.